Logo image of COSM

COSMOS HEALTH INC (COSM) Stock Fundamental Analysis

USA - NASDAQ:COSM - US2214133058 - Common Stock

1.08 USD
-0.01 (-0.92%)
Last: 9/26/2025, 8:00:00 PM
1.0698 USD
-0.01 (-0.94%)
After Hours: 9/26/2025, 8:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to COSM. COSM was compared to 101 industry peers in the Health Care Providers & Services industry. COSM has a bad profitability rating. Also its financial health evaluation is rather negative. COSM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

COSM had negative earnings in the past year.
In the past year COSM has reported a negative cash flow from operations.
In the past 5 years COSM reported 4 times negative net income.
COSM had a negative operating cash flow in each of the past 5 years.
COSM Yearly Net Income VS EBIT VS OCF VS FCFCOSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

COSM has a Return On Assets of -37.29%. This is amonst the worse of the industry: COSM underperforms 89.11% of its industry peers.
Looking at the Return On Equity, with a value of -82.19%, COSM is doing worse than 76.24% of the companies in the same industry.
Industry RankSector Rank
ROA -37.29%
ROE -82.19%
ROIC N/A
ROA(3y)-58.08%
ROA(5y)-40.78%
ROE(3y)-108%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
COSM Yearly ROA, ROE, ROICCOSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

1.3 Margins

COSM has a worse Gross Margin (9.39%) than 74.26% of its industry peers.
COSM's Gross Margin has declined in the last couple of years.
COSM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.83%
GM growth 5Y-3%
COSM Yearly Profit, Operating, Gross MarginsCOSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

1

2. Health

2.1 Basic Checks

COSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, COSM has more shares outstanding
Compared to 5 years ago, COSM has more shares outstanding
COSM has a worse debt/assets ratio than last year.
COSM Yearly Shares OutstandingCOSM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
COSM Yearly Total Debt VS Total AssetsCOSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -2.04, we must say that COSM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of COSM (-2.04) is worse than 86.14% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that COSM is not too dependend on debt financing.
COSM has a better Debt to Equity ratio (0.19) than 68.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z -2.04
ROIC/WACCN/A
WACC7.23%
COSM Yearly LT Debt VS Equity VS FCFCOSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 1.05 indicates that COSM should not have too much problems paying its short term obligations.
COSM has a worse Current ratio (1.05) than 71.29% of its industry peers.
A Quick Ratio of 0.87 indicates that COSM may have some problems paying its short term obligations.
COSM's Quick ratio of 0.87 is on the low side compared to the rest of the industry. COSM is outperformed by 72.28% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.87
COSM Yearly Current Assets VS Current LiabilitesCOSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.63% over the past year.
Looking at the last year, COSM shows a decrease in Revenue. The Revenue has decreased by -3.69% in the last year.
COSM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.52% yearly.
EPS 1Y (TTM)47.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.66%
Revenue 1Y (TTM)-3.69%
Revenue growth 3Y-1.09%
Revenue growth 5Y6.52%
Sales Q2Q%-5.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y101.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COSM Yearly Revenue VS EstimatesCOSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
COSM Yearly EPS VS EstimatesCOSM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 0 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

COSM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 105.88, which means the current valuation is very expensive for COSM.
COSM's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.05, COSM is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 105.88
COSM Price Earnings VS Forward Price EarningsCOSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
COSM Per share dataCOSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 1.5

4.3 Compensation for Growth

COSM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

COSM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COSMOS HEALTH INC

NASDAQ:COSM (9/26/2025, 8:00:00 PM)

After market: 1.0698 -0.01 (-0.94%)

1.08

-0.01 (-0.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-26 2025-08-26
Earnings (Next)11-12 2025-11-12
Inst Owners3.33%
Inst Owner Change-63.04%
Ins Owners28.16%
Ins Owner Change13.04%
Market Cap32.63M
Analysts82.86
Price Target3.06 (183.33%)
Short Float %2.04%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.55%
Min Revenue beat(2)-13.27%
Max Revenue beat(2)-3.83%
Revenue beat(4)0
Avg Revenue beat(4)-11.32%
Min Revenue beat(4)-15.09%
Max Revenue beat(4)-3.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 105.88
P/S 0.61
P/FCF N/A
P/OCF N/A
P/B 1.26
P/tB 1.8
EV/EBITDA N/A
EPS(TTM)-1.04
EYN/A
EPS(NY)0.01
Fwd EY0.94%
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS1.77
BVpS0.86
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.29%
ROE -82.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.39%
FCFM N/A
ROA(3y)-58.08%
ROA(5y)-40.78%
ROE(3y)-108%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.83%
GM growth 5Y-3%
F-Score5
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 95.88%
Cap/Sales 2.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 0.87
Altman-Z -2.04
F-Score5
WACC7.23%
ROIC/WACCN/A
Cap/Depr(3y)567.53%
Cap/Depr(5y)400.27%
Cap/Sales(3y)5.71%
Cap/Sales(5y)3.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.66%
EPS Next Y101.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.69%
Revenue growth 3Y-1.09%
Revenue growth 5Y6.52%
Sales Q2Q%-5.98%
Revenue Next Year25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y70.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.2%
OCF growth 3YN/A
OCF growth 5YN/A